You are viewing: North America Microbiology Testing Market analysis
Part of: Microbiology Testing Market (Global)

The North America Microbiology Testing Market was valued at $814.4 Million in 2025 and projected to reach to $1006.7 Million by 2030, representing a compound annual growth rate of 3.7%. North America's microbiology testing market is positioned for steady growth through 2030, supported by stringent regulatory requirements, increasing prevalence of infectious diseases, and heightened focus on food and pharmaceutical safety.

North America Microbiology Testing Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Microbiology Testing Market Trends and Insights

  • North America's mature healthcare infrastructure and advanced diagnostic capabilities position the region as a significant player in global microbiology testing.
  • The market in North America is driven by increasing demand for rapid diagnostic solutions, stringent regulatory standards, and growing prevalence of infectious diseases across the United States and Canada. North America's microbiology testing sector benefits from substantial investments in healthcare technology and a well-established network of clinical laboratories.
  • The region's emphasis on infection prevention and control, coupled with rising awareness of antimicrobial resistance, continues to fuel demand for comprehensive microbiology testing services.
  • Between 2025 and 2030, North America is expected to maintain steady growth as healthcare providers prioritize accurate and timely microbial identification and susceptibility testing. Key factors supporting North America's market expansion include aging populations, increased hospital-acquired infection monitoring, and the integration of automation in laboratory workflows.
  • North America's regulatory environment and reimbursement landscape further support sustained investment in microbiology testing infrastructure and innovation..

Key Market Statistics

  • CAGR (2025-2030) 3.7% CAGR
  • Market Size, 2025 ~USD 814.4 Million
  • Forecast, 2030 ~USD 1006.7 Million
  • Geography North America

North America Microbiology Testing Market Overview

Mature Healthcare Infrastructure :

North America's advanced diagnostic capabilities and well-established healthcare systems drive consistent demand for microbiology testing services across clinical, pharmaceutical, and food safety sectors.

US Market Dominance :

The United States represents the largest microbiology testing market in North America at $908.6 million, accounting for the majority of regional growth and innovation in diagnostic technologies.

Steady Regional Growth :

The North American market is projected to expand from $814.4 million in 2025 to $1,006.7 million by 2030, reflecting a 3.7% CAGR driven by regulatory compliance and infection control initiatives.

Canada's Significant Contribution :

Canada's microbiology testing market valued at $368.3 million demonstrates strong healthcare investment and supports the region's overall market expansion through robust laboratory infrastructure.

North America Microbiology Testing Market Dynamics

  • The region's mature healthcare infrastructure and advanced laboratory capabilities enable rapid adoption of innovative diagnostic technologies and automation solutions. Key growth drivers include rising antimicrobial resistance concerns, expanding clinical laboratory networks, and increased investment in diagnostic infrastructure.
  • While the 3.7% regional CAGR is moderate compared to the global 5.3%, North America maintains its position as a premium market with high-value diagnostic services and sophisticated testing methodologies that command significant market share..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • North America's microbiology testing market will grow from $814.4M (2025) to $1,006.7M (2030) at a 3.7% CAGR.
    • North America's advanced healthcare infrastructure and regulatory standards drive demand for rapid and accurate diagnostic testing.
    • Antimicrobial resistance awareness and infection prevention initiatives are key growth catalysts in North America.
    • North America's aging population and hospital-acquired infection monitoring support sustained market expansion through 2030.

    Microbiology Testing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment VIRAL (Pathogen Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.3% from 2025 to 2030
    Largest Segment TRADITIONAL MICROBIOLOGY METHODS (TMM) (Technology Type)
    Market Size Base Year (Billions) ~USD 7.4 (2025)
    Revenue Forecast (Billions) ~USD 9.58 (2030)
    Segments Covered Product, Type, Technology Type, Pathogen Type, End User, Technology, End Users

    North America Microbiology Testing Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments
    • Reagents & Kits

    By Type

    • Automated Culture Systems
    • Cellular Component-Based Rapid Microbiology Testing
    • Colony Counters
    • Culture Methods
    • Growth-Based Rapid Microbiology Testing
    • Incubators
    • Manual Counting Methods
    • Mass Spectrometers
    • Microscopes
    • Microscopy Methods
    • Nucleic Acid-Based Rapid Microbiology Testing
    • Other Instruments
    • Other Traditional Microbiology Methods
    • Staining Techniques
    • Viability-Based Rapid Microbiology Testing

    By Technology Type

    • Rapid Microbiology Methods (Rmm)
    • Traditional Microbiology Methods (Tmm)

    By Pathogen Type

    • Bacterial
    • Fungal
    • Other Pathogens
    • Viral

    By End User

    • Cosmetics & Personal Care Companies
    • Environmental & Water Testing
    • Food & Beverage Companies
    • Other End Users
    • Pharmaceutical & Biotech Companies

    By Technology

    • Rapid Microbiology Methods (Rmm)
    • Traditional Microbiology Methods (Tmm)

    By End Users

    • Cosmetics & Personal Care Companies
    • Environmental & Water Testing
    • Food & Beverage Companies
    • Other End Users
    • Pharmaceutical & Biotech Companies

    Target Audience

    • Diagnostic Equipment Manufacturers : Need market sizing and growth forecasts for North America to develop region-specific product strategies and identify opportunities in the $1B+ market by 2030.
    • Clinical Laboratory Operators : Require competitive benchmarking and market trends to optimize service portfolios, pricing strategies, and investment in automation technologies across US and Canadian markets.
    • Healthcare Investors & PE Firms : Seek detailed market analysis and country-level data to evaluate acquisition targets, assess portfolio company performance, and identify consolidation opportunities in North America.
    • Pharmaceutical & Biotech Companies : Need microbiology testing market insights to support clinical trial planning, regulatory submissions, and quality assurance operations in North American markets.
    • Healthcare Consultants & Strategy Firms : Require comprehensive regional data and forecasts to advise clients on market entry, competitive positioning, and growth strategies in the North American diagnostic sector.

    Key Companies in the North America Microbiology Testing Market

    CompanyHQOwnershipStrongest segments
    BIOMÉRIEUXFrancePublic CompanySyndromic and low-plex PCR (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE),Microbiology ID/AST and blood culture (VITEK 2, VITEK MS, VITEK REVEAL, BACT/ALERT, ETEST, API),Immunoassays and sepsis markers (VIDAS, Hybiome CLIA),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    MERCK KGAAGermanyPublic CompanyLife Science (lab and bioprocessing),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials),
    NEOGEN CORPORATIONUnited StatesPublic CompanyFood Safety diagnostics, media, and sanitation,Animal Safety reagents, instruments, and animal care products,Genomics services for livestock and companion animals,
    QIAGENNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB and transplant/viral load assays),Oncology and sexual/reproductive health assays,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyLife Science instruments and systems,Life Science reagents and consumables,Clinical diagnostic test systems and informatics,
    BRUKERUnited StatesPublic CompanyNMR/EPR and Preclinical Imaging (BSI BioSpin),Mass Spectrometry, Molecular Diagnostics, and CALID Solutions,X-ray, AFM, and Nano-Analysis (BSI Nano),
    SHIMADZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems,Industrial and Vacuum Machinery,
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    EUROFINS SCIENTIFICLuxembourgPublic CompanyFood and Feed Testing, Assurance and Certification,Environment Testing (water, air, soil, waste, maritime),Biopharma Services and Clinical Diagnostics,
    IDEXXUnited StatesPublic CompanyCompanion Animal Group (in-clinic analyzers, SNAP tests, reference labs, telemedicine, software),Water Quality Products,Livestock, Poultry and Dairy plus Human Diagnostics,

    BIOMÉRIEUX

    bioMérieux is a French public company founded in 1963 that employs 14,894 people. The company operates in the life sciences and diagnostics sector.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a major player in the life sciences and laboratory services industry.

    MERCK KGAA

    Merck KGaA is a German public company with roots dating back to 1668 and currently employs 59,077 people. The company operates across pharmaceuticals, life sciences, and specialty chemicals.

    NEOGEN CORPORATION

    Neogen Corporation is a United States-based public company founded in 1981 with 2,974 employees. The company provides food and animal safety solutions.

    QIAGEN

    QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company specializes in molecular diagnostics and life sciences technologies.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.

    BRUKER

    Bruker is a United States-based public company founded in 1960 with 11,085 employees. The company develops scientific instruments and analytical solutions for research and diagnostics.

    SHIMADZU CORPORATION

    Shimadzu Corporation is a Japanese public company founded in 1875 with 14,649 employees. The company manufactures analytical and measuring instruments, medical devices, and industrial equipment.

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services for drug development.

    EUROFINS SCIENTIFIC

    Eurofins Scientific is a Luxembourg-based public company founded in 1987 with 65,694 employees. The company operates a network of laboratories providing testing and analytical services across multiple industries.

    IDEXX

    IDEXX is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostics and software for veterinary and water testing markets.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 710.3 Million · 3.2% wtd CAGR ·
    Asia Pacific
    ~USD 634 Million · 5.9% wtd CAGR ·
    Latin America
    ~USD 166.4 Million · 4.9% wtd CAGR ·
    Middle East & Africa
    ~USD 136.4 Million · 5.5% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 908.6 Million
    CanadaUSD 368.3 Million

    Country market size visualization

    US
    USD 908.6 Million
    Canada
    USD 368.3 Million

    Reasons to Buy this Report

    • Country-Level Market Breakdown : Access detailed market sizing for US ($908.6M) and Canada ($368.3M) to identify high-value opportunities and regional investment priorities within North America.
    • Competitive Landscape Intelligence : Understand market dynamics specific to North America's mature healthcare environment, including key players, service offerings, and competitive positioning strategies.
    • Growth Trajectory Analysis : Leverage 5-year forecast data (2025-2030) to plan product launches, market entry strategies, and resource allocation for North American expansion.
    • Regulatory & Compliance Insights : Gain region-specific knowledge of FDA, Health Canada, and other regulatory requirements driving microbiology testing demand and market standardization.
    • Strategic Investment Guidance : Identify high-growth segments and underserved markets within North America to optimize capital allocation and maximize ROI in the diagnostic testing sector.

    Frequently asked questions

    What is the current size of the microbiology testing market in North America?

    The North America microbiology testing market is valued at $814.4 million in 2025.

    What is the projected market size for North America microbiology testing by 2030?

    North America's microbiology testing market is projected to reach $1,006.7 million by 2030.

    What is the growth rate for microbiology testing in North America?

    North America's microbiology testing market is expected to grow at a compound annual growth rate of 3.7% from 2025 to 2030.

    What factors are driving growth in North America's microbiology testing market?

    Key drivers in North America include rising antimicrobial resistance awareness, infection prevention initiatives, aging populations, and increased hospital-acquired infection monitoring.

    How does North America's microbiology testing market compare to global trends?

    North America's 3.7% CAGR is more conservative than the global 5.3% CAGR, reflecting the region's mature market status and established diagnostic infrastructure.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics of the microbiology testing sector, including drivers, opportunities, restraints, challenges, and key player strategies. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. The competitive landscape is evaluated to assess market players across various parameters within the broad categories of business and product strategy. The market size is estimated using top-down and bottom-up approaches, while market breakdown and data triangulation methods are employed to determine segment and subsegment sizes.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    Microbiology Testing Market Size, and Share

    Note 1: Others include sales managers, marketing managers, and product managers.
    Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both the top-down and bottom-up approaches have been used to estimate and validate the size of the small satellite market.

    The top-down and bottom-up approaches were used to estimate and validate the total size of the microbiology testing market. These methods were also widely used to estimate the sizes of various market segments. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research.
    • The revenues generated by leading players operating in the microbiology testing industry have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Microbiology Testing Market : Top-Down and Bottom-Up Approach

    Microbiology Testing Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size using the above-mentioned process, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides.

    Market Definition

    Microbiology testing involves the identification, quantification, and analysis of microorganisms, including bacteria, viruses, fungi, and protozoa, and plays a critical role in ensuring product safety, protecting public health, and preserving environmental integrity. These tests are widely used across pharmaceutical and biotech companies, food and beverage companies, environmental and water testing, cosmetics and personal-care companies, the agriculture and animal feed industry, and academic and research institutes, where they support quality control, regulatory compliance, contamination monitoring, and scientific research activities.

    Key Stakeholders

    • Manufacturers & distributors of microbiology testing solutions
    • Food & beverage companies
    • Environmental and water testing organizations
    • Pharmaceutical & biotechnology companies
    • Cosmetics & personal care companies
    • Agriculture & animal feed industry
    • Contract testing laboratories
    • Academic & research institutes
    • Government and regulatory bodies
    • Market research & consulting firms
    • Venture capitalists & investors

    Report Objectives

    • To define, segment, and forecast the global microbiology testing market by product, technology, pathogen type, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall microbiology testing market 
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the microbiology testing market using the company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

    Available customizations:

    MarketsandMarkets offers the following customizations for this market report.

    Company Profiles

    • An additional five company profiles of players operating in microbiology testing.

    Regional Analysis

    • Further breakdown of the market segments at the country level

    Country Information

    • Additional country-level analysis of microbiology testing

     

    Get the Full Microbiology Testing Market Report

    Full forecast, segment splits, and company analysis for all Microbiology Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status